Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 9,200 shares at $2.15 ($20K) on 2024-07-24, disclosed to the SEC on 2024-07-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.07 | 3,200 | $7K | 33.9% |
| 2 | $2.15 | 6,000 | $13K | 66.1% |
| Total | $2.12 avg | 9,200 | $20K | 100% |
| Filing → |
| IMMX | BUY | 2023-12-12 | $267K | — | Filing → |
| IMMX | BUY | 2023-09-18 | $200K | — | Filing → |
| IMMX | BUY | 2023-09-12 | $25K | — | Filing → |